Company attributes
Other attributes
Arthronica was a London-based medical research start-up that focused on chronic arthritis. The company was spun out from the bioengineering department at Imperial College London in 2018. Arthronica was headed by founder and CEO Letizia Gionfrida, a researcher and participant in the MedTech SuperConnector accelerator. The company entered liquidation in September 2021 and was acquired by Procedure Health Limited in March 2022.
Arthronica was a software-as-a-service (SaaS) platform to remotely diagnose arthritis. The platform relied on patients' smartphone or laptop cameras as well as artificial intelligence software. Arthronica was designed to provide rapid data access to both patients and doctors in order to optimize recovery.
Arthronica raised over 1.2 million pounds in a 2020 pre-seed round. Investors in the round included AI Seed, Crista Galli Ventures, Entrepreneur First, RebelBio and SOSV.
